The Synthetics, Part I: Designer Drugs on the Horizon Led by Dr. Daniela Zaborskis and featuring Senior Researcher, Mumtaz Akhtar
Our Summer Webinar has provided a review and expert opinion in a discussion on the pharmacological, medical and social implications of designer drugs: synthetic cannabinoids and fentanyl analogs.
The prevalence of these substances constitutes a crisis, which compels us to hone our understanding of these substances, and to better deliver the most effective diagnoses and care.
The seminar offered:
A summary of two types of designer drugs: fentanyl analogs and synthetic cannabinoids
A review of the basic pharmacology of these dangerous and illicit substances
A discussion of the seemingly innumerable varieties of drugs being abused
Moderator:
PhD, Director of Operations and Senior Scientist
Featuring
Mumtaz Akhtar Acutis’ Senior Researcher
These and other relevant areas of interest were illustrated with case studies and specific “take-home” points.
In addition to having the opportunity to participate in an important and focused discussion, participants earned continuing medical education credits.
Colleagues, peers and participants can download the contents of our Summer Webinar below.
Comments